Variations in End‐of‐Life Care and Place of Death Among People With Neurodegenerative Diagnoses: A Nationwide Registry‐Based Study
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2026 (1) , 7600145
Abstract
Background: Neurodegenerative diseases involve progressive deterioration and high symptom burden, requiring both neurological and palliative care. This study is aimed at identifying trends and variations in place of death for adult people with neurodegenerative diagnoses in Sweden using registry data, and at examining potential associations between place of death and individual characteristics, clinical, geographical and socioeconomic factors. Motor neuron disease, Parkinson′s disease and multiple sclerosis, representing the three largest diagnostic groups within the applied classification, were analysed separately. Methods: A population registry study examined the place of death in people with neurodegenerative diagnoses between 2013 and 2019. Descriptive statistics and linear regression models were applied. Results: A total of 9007 deaths were identified. Most occurred in nursing homes (50.5%), followed by hospitals (33.6%) and private homes (15.2%). No consistent temporal trends in place of death were observed. People with motor neuron disease and multiple sclerosis most commonly died in hospital, whereas those with Parkinson′s disease mainly died in nursing homes. Only 9.4% were assigned the ICD‐10 code Z51.5 for palliative care, and 90.5% did not utilise specialised palliative care at death. Region Stockholm, the capital region of Sweden, had the highest proportion of hospital deaths (38.5%). Among individuals living at home, a higher likelihood of hospital death was associated with residing in Stockholm, experiencing one or more hospital transfers, or having unplanned emergency department visits, whereas lower likelihood was associated with recorded utilisation of specialised palliative care. Conclusions: Place of death remained stable over time, with limited use of specialised palliative care. Hospital transfers in the last month of life were strongly associated with hospital death, alongside substantial regional and diagnosis‐specific variation. These findings highlight regional and diagnosis‐specific variations in end‐of‐life care, which may indicate potential inequities, and suggest that earlier integration of neuropalliative care and greater consistency in the organisation of palliative care across regions warrant further consideration and evaluation.Keywords
This publication has 41 references indexed in Scilit:
- Research Priorities in Neuropalliative CareJAMA Neurology, 2025
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet Neurology, 2024
- Palliative care to support the needs of adults with neurological diseaseThe Lancet Neurology, 2023
- Were Clinical Routines for Good End-of-Life Care Maintained in Hospitals and Nursing Homes During the First Three Months of the Outbreak of COVID-19? A National Register StudyJournal of Pain and Symptom Management, 2021
- Treatment of Multiple Sclerosis: A ReviewThe American Journal of Medicine, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Symptom relief during last week of life in neurological diseasesBrain and Behavior, 2019
- End-of-life care—what do cancer patients want?Nature Reviews Clinical Oncology, 2013
- Quality Indicators for Palliative Care: Update of a Systematic ReviewJournal of Pain and Symptom Management, 2013
- Generalist plus Specialist Palliative Care — Creating a More Sustainable ModelNew England Journal of Medicine, 2013